Live Webinars

Society for Health Psychology Co-Sponsored Webinar

Presenter: Drs. Hana Kim and Grace Kao

Hana Kim, PhD, ABPP-Lieutenant Commander; US Public Health Service (USPHS). Dr. Hana Kim is an active duty psychologist within the U.S. Public Health Service (USPHS), one of the eight uniformed services in the nation. The mission of the USPHS is to protect, promote and advance the health and safety of the general public. She is board-certified in Health Psychology through the American Board of Professional Psychology. She has primarily worked with veteran and active duty populations in the past 15 years and is currently stationed with the U.S. Coast Guard (USCG), responsible for overseeing behavioral health services for the Mid-Atlantic region to include the USCG’s sole accession training center. 

Grace Kao, PhD, ABPP, University of Texas MD Anderson Cancer Center. Dr. Kao a pain psychologist and associate professor at The University of Texas MD Anderson Cancer Center. She is also the founding psychologist of the interdisciplinary chronic pain clinic at Texas Children's Hospital and former faculty clinician at Baylor College of Medicine. Dr. Kao is board-certified in clinical health psychology and well- practiced in cognitive behavioral therapy and acceptance and commitment therapy, with additional expertise in pediatric care, clinical hypnosis, and biofeedback. Professionally, she spends her time supporting patients and families who are navigating health and pain symptoms, providing instruction, consultation, and advisory board service and engaging in clinical research in the area of pain psychology. Additionally, she enjoys narrative writing and continually welcomes opportunities to write about health and healing.   Overview:          This webinar will explore the intersection of DEI and education and training from the perspective of both research and clinical training. Our two expert speakers will share insights in each of these domains, particularly within the current landscape of practice. Our four objectives are: Describe how to use the ADDRESSING formulation within clinical supervision; Identify 2 methods by which to integrate DEI into clinical supervision; Describe the value of DEI to research and science for all; and Become more aware of differences between directed actions vs. pre-emptive adherence and why this distinction is important. Target audience is intermediate.

Learning Objectives: Intended Audience: Introductory

1. Describe a mindful parenting approach and benefits for stress reduction. 
2. Describe the philosophy of minimalist parenting for the newborn to the pre -teen years and benefits for time management. 
3. Discuss how mindful parenting and minimalist parenting practices may be applied to support both parent and child well-being. 

Presenter:  Dr. Carroll Cradock

Overview:          Psychotherapy is approaching a transition that will broadly and deeply transform practice. Over the past few years, it has become clear that psychotherapy clients can get better sooner and stay better longer when the therapist or counselor integrates visual tools with talk therapy. The visual techniques in this presentation include two types: virtual tools and tangible tools (personal and household objects). These visual tools are appropriate for use in mental health care for adults, adolescents and children. The visual approaches in this presentation are intended for use during therapy sessions, between therapy sessions and post-therapy. Their visibility renders the clinical significance salient for the client, yet invisible to others and protective of client privacy. The empirical bases for use of these tools include research on clinical psychology, psychotherapy, visual perception and social psychology.

Presenter Bio: Carroll Cradock, Ph.D., President CAC Counseling LLC Expertise in providing presentations and content: Over 60 presentations and webinars: virtual and in person, including topics on use of visuals in therapy Taught courses in psychotherapy (adults, children, adolescents) in 3 Chicago doctoral programs in clinical psychology President, Chicago Campus, The Chicago School of Professional Psychology 2009-2011

Learning Objectives:

1. Explain rationale and evidence base for use of visible, versatile and confidential visual tools to promote and sustain benefits of psychotherapy for anxiety: ordinary personal and household objects and virtual visuals.
2. Describe at least three examples of visual tools effective in treatment and relapse prevention of anxiety
3. Specify three (3) steps in selecting and using visual tools effectively during psychotherapy sessions.

Presenter: Stephanie Knatz Peck Ph.D. Dr. Stephanie Knatz Peck (Ph.D)  is a clinical psychologist and Voluntary Associate Clinical Professor at the University of California, San Diego Department of Psychiatry.. She served as co-investigator on two trials evaluating psilocybin for anorexia nervosa and served as lead psychologist on  trials evaluating psilocybin for treatment resistant depression and anorexia nervosa. She has experience delivering both psilocybin therapy and ketamine-assisted therapy for mental health populations, and is also trained in psychological support models for other psychedelic drugs. She has served as a senior clinical consultant, subject matter expert and lead content developer for  Compass Pathways assisting with the development of content related to their psychological support model and therapist training program for indications including treatment resistant depression and anorexia nervosa. She currently provides ongoing training  for Compass clinical trial therapists. Stephanie is passionate about developing and disseminating psychedelic therapy models in mainstream clinical settings that support safe and healing psychedelic experiences for mental health populations.  

 Overview:          Psychiatric illnesses affect a large proportion of the population and can be costly and difficult to treat successfully. Despite their seriousness to society, there have been minimal advancements in novel behavioral treatment strategies and stagnant outcomes over the past several decades. Novel and innovative treatments methods are urgently needed to improve treatment engagement and outcomes (Grinstein, 2024). One such avenue may be psychedelic treatment, which includes the supported delivery of psychedelic medicine delivered in conjunction with therapy. There has been a surgency of interest and study of psychedelic treatments, including rigorous, randomized controlled trials for major depressive disorder and substance use disorders, and smaller studies underway for a number of other mental health indications (Vollenweider & Preller, 2020; Sicignano, Hernandez, Schiff, Elmahy,& White, 2024). Results from these studies indicate significant promise, in some cases for otherwise treatment resistant populations and pathways for approval of these treatments are currently being pursued to facilitate therapeutic access legally to those who may benefit (Van Amsterdam & van den Brink, 2022). Psychologists will need to be prepared for the advent of these novel treatment models. This presentation will provide an overview of the current state of the literature with a particular focus on the state of the evidence for psychedelic treatments and mental health indications for which there may be promise based on available studies, and current knowledge related to mechanisms of action (van Elk & Yaden, 2022).

Learning Objectives: 

1. Describe the basic framework being studied for providing psychological support alongside psychedelic medicines
2. Explain the current state of the research for psychedelic treatments in clinical settings.
3. List mental illnesses for which psychedelic treatments may be indicated based on extant research,

CE Credits Available: 1.0 

PLEASE NOTE: You must sign in to receive the Member discount. After purchasing, you must follow the link in your receipt provided to REGISTER for the webinar via Zoom. It is a 2-step process. If a link does not appear, contact us. 

Cancellation Policy: No refunds will be provided except when SCP cancels the webinar. 

The Society of Clinical Psychology, Division 12 nor Dr. Knatz  have commercial support for the content of this webinar including endorsement of products, conflict of interest including but not limited to research grants, royalties for books or training, commercial support from companies or pharmaceutical sponsorship.  Attendees must attend the entirety of the program and complete the Evaluation sent after the program.  Evaluations will be sent via email shortly after the Live webinar.  CE Certificates will be processed and emailed within 5 – 10 business days from Live Webinar.

If you require any special needs assistance, please contact the SCP Central Office at [email protected]. 

Presenter:  J. Kim Penberthy, Ph.D., ABPP Dr. J. Kim Penberthy is a board-certified clinical psychologist and Professor of Psychiatry and Neurobehavioral Sciences at the University of Virginia School of Medicine. She specializes in the integration of contemplative practices—such as mindfulness, self-compassion, and meaning-centered interventions—into psychotherapy and clinical care. Her work focuses on serious illness, end-of-life concerns, and spiritual and existential aspects of psychological wellbeing. Dr. Penberthy has published extensively on mindfulness-based interventions, spiritual and religious issues in clinical practice, and the interface between science and contemplative wisdom. She is a founding member of the UVA Contemplative Sciences Center and has led national workshops and trainings on integrating mindfulness and meaning-making into medical and psychological care. Her clinical experience includes working with individuals facing terminal illness, prolonged grief, and death anxiety. Her background uniquely qualifies her to speak on how contemplative approaches can support individuals navigating fear of death and grief after loss, while also training clinicians to recognize and respond to non-ordinary experiences in a respectful, non-pathologizing manner.   Overview:          In both clinical and contemplative settings, individuals frequently report experiences that fall outside ordinary waking consciousness—such as near-death experiences, after-death communications, spiritual awakenings, and spontaneous mystical states. While these may superficially resemble psychopathological symptoms (e.g., hallucinations, dissociation, delusions), many such experiences are deeply meaningful, culturally normative, or even transformative. Clinicians and researchers are increasingly called upon to make nuanced distinctions between psychopathology and non-ordinary experiences (NOEs), especially in contexts of grief, trauma, spiritual practice, or end-of-life care. This session explores the complexity of this clinical discernment. Participants will learn frameworks for distinguishing between pathology and non-pathology, considering factors such as: intact reality testing, cultural context, degree of distress or functional impairment, and the presence of integration or insight following the experience (Lukoff, Lu, & Turner, 1998; Grof & Grof, 1989). We will also examine how diagnostic systems such as the DSM-5 acknowledge spiritual or religious experiences through the "Religious or Spiritual Problem" V code (American Psychiatric Association, 2013). Drawing from transpersonal psychology, contemplative science, and trauma-informed care, we advocate for an integrative and culturally sensitive approach that avoids pathologizing the extraordinary. Case studies will illustrate how misdiagnosis can lead to unnecessary treatment, while respectful inquiry and meaning-centered dialogue can facilitate posttraumatic growth and healing (Corcoran & Walsh, 2010; Greyson, 2000). This session invites participants to explore how clinicians, caregivers, and contemplative practitioners can skillfully hold space for NOEs—balancing curiosity and compassion with clinical responsibility.

Learning Objectives: Intended Audience: Intermediate

1. Describe the diagnostic criteria approach for psychiatric disorders, including what defines a psychopathology.
2. Describe non-ordinary experiences that patients may report, including spontaneous and induced experiences such as near death experiences and out-of-body experiences.
3. Describe how to approach a patient who is reporting non-ordinary experiences in order to optimize understanding and healing.

The Society of Clinical Psychology, Division 12 and Dr. Penberthy do not have commercial support for the content of this webinar including endorsement of products, conflict of interest including but not limited to research grants, royalties for books or training, commercial support from companies or pharmaceutical sponsorship. If you require any special needs assistance, please contact the SCP Central Office at [email protected].